Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

Astellas

Status: Completed

Conditions: Chronic Renal Failure

Treatments: Drug: bixalomer

Study type: Observational

Funder types: Industry

Identifiers

NCT01903213

KIK002

Details and patient eligibility

About

To evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.

Enrollment: 123 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Chronic renal failure patients with Hyperphosphatemia receiving peritoneal dialysis

Trial design

123 participants in 1 patient group

Kiklin group

Description:

Oral

Treatment:

Drug: bixalomer